GLOBUS MED INC's ticker is GMED and the CUSIP is 379577208. A total of 371 filers reported holding GLOBUS MED INC in Q4 2021. The put-call ratio across all filers is 0.49 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,689,342 | -30.0% | 34,025 | -16.1% | 0.29% | -52.7% |
| Q2 2023 | $2,414,645 | +5.1% | 40,555 | 0.0% | 0.61% | +5.7% |
| Q1 2023 | $2,297,035 | -23.5% | 40,555 | +0.2% | 0.58% | -24.9% |
| Q4 2022 | $3,004,593 | +26.7% | 40,455 | +1.7% | 0.77% | +17.5% |
| Q3 2022 | $2,371,000 | -4.5% | 39,794 | -10.0% | 0.66% | -8.6% |
| Q2 2022 | $2,483,000 | -29.9% | 44,227 | -7.8% | 0.72% | -34.4% |
| Q1 2022 | $3,540,000 | -1.4% | 47,983 | -3.5% | 1.10% | -5.1% |
| Q4 2021 | $3,591,000 | +502.5% | 49,734 | +539.3% | 1.16% | +439.7% |
| Q3 2021 | $596,000 | -0.3% | 7,779 | -35.6% | 0.21% | -43.7% |
| Q3 2020 | $598,000 | +53.7% | 12,083 | +48.0% | 0.38% | +9.5% |
| Q2 2020 | $389,000 | +8.7% | 8,163 | -3.2% | 0.35% | +7.4% |
| Q1 2020 | $358,000 | -44.8% | 8,429 | -23.4% | 0.32% | -3.3% |
| Q4 2019 | $648,000 | – | 10,999 | – | 0.33% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Consonance Capital Management LP | 908,953 | $59,282,000 | 5.54% |
| Sterling Investment Advisors, Ltd. | 234,623 | $15,302,000 | 5.20% |
| Next Capital Management LLC | 111,098 | $7,246,000 | 5.10% |
| Godshalk Welsh Capital Management, Inc. | 77,085 | $5,027,000 | 3.71% |
| Pembroke Management, LTD | 613,931 | $40,041,000 | 3.36% |
| XXEC, Inc. | 52,800 | $3,444,000 | 2.71% |
| Global Alpha Capital Management Ltd. | 302,377 | $19,721,000 | 2.42% |
| Van Berkom & Associates Inc. | 1,572,303 | $102,546,000 | 2.35% |
| PARADIGM CAPITAL MANAGEMENT INC/NY | 581,700 | $37,939,000 | 2.27% |
| RTW INVESTMENTS, LP | 1,640,859 | $107,017,000 | 1.80% |